Suchergebnisse - (Subject:"COVID-19")

PubPharm (346.309)

51

Prevalence of SARS-CoV-2-specific antibodies in a sample of the Lithuanian population-based study in Spring 2023

enthalten in: Heliyon | 2024

von Simanavičius, M. | Kučinskaitė-Kodzė, I. | Kaselienė, S. | +8

52

Cognition, affect, and behavioural changes among university students after 10 new guidelines were issued in China : An exploratory study

enthalten in: Heliyon | 2024

von Sun, Z. | Zhang, Y. | Zhang, W. | +2

53

Trial to Evaluate the Efficacy and Safety of Nitazoxanide (NTZ) for Pre- and Post Exposure Prophylaxis of COVID-19 and Other Viral Respiratory Illnesses (VRI) in Healthcare Workers and Others at Increased Risk of SARS-CoV-2 Infection : A Randomized, Double-Blind, Placebo Controlled Trial to Evaluate the Efficacy and Safety of Nitazoxanide (NTZ) for Pre- and Post Exposure Prophylaxis of COVID-19 and Other Viral Respiratory Illnesses (VRI) in Healthcare Workers and Others at Increased Risk of SARS-CoV-2 Infection

enthalten in: ClinicalTrials.gov | 2024

54

A Phase 2b/3, Randomized, Observer-Blinded, Placebo-Controlled, Multicenter Clinical Study Evaluating the Efficacy and Safety of Investigational SARS-CoV-2 mRNA Vaccine CVnCoV in Adults 18 Years of Age and Older : COVID-19: A Phase 2b/3, Randomized, Observer-Blinded, Placebo-Controlled, Multicenter Clinical Study Evaluating the Efficacy and Safety of Investigational SARS-CoV-2 mRNA Vaccine CVnCoV in Adults 18 Years of Age and Older

enthalten in: ClinicalTrials.gov | 2024

55

Cohort Assessing the Immunogenicity and the Safety of the COVID-19 Vaccine Janssen in Healthy Volunteers Based on 2 Age Groups: 65 Years or Older - 55 to 65 Years. Covicompare-Janssen : Cohort Assessing the Immunogenicity and the Safety of the COVID-19 Vaccine Janssen in Healthy Volunteers Based on 2 Age Groups: 65 Years or Older - 55 to 65 Years. Covicompare-Janssen

enthalten in: ClinicalTrials.gov | 2024

56

Study Assessing the Feasibility, Safety and Efficacy of Genetically Engineered Glucocorticoid Receptor Knock Out Virus Specific CTL Lines for Viral Infections in Immunosuppressed Cancer Patients : Study Assessing the Feasibility, Safety and Efficacy of Genetically Engineered Glucocorticoid Receptor Knock Out Virus Specific CTL Lines for Viral Infections in Immunosuppressed Cancer Patients

enthalten in: ClinicalTrials.gov | 2024

57

A Study Evaluating Tocilizumab in Pediatric Patients Hospitalized With COVID-19 : A Phase Ib, Single-Arm, Open-Label Study Evaluating the Pharmacokinetics, Pharmacodynamics, and Safety of Tocilizumab in Pediatric Patients Hospitalized With COVID-19

enthalten in: ClinicalTrials.gov | 2024

58

Sars-COV-2 (COVID-19) Immunity in immunoCOmpromised Populations : Longitudinal Follow-up of SARS-CoV-2 (COVID-19) Immunity in Immunocompromised Populations in Belgium (COVICO) in Nursing Home Residents and Staff During the Winter Season 2022-2023

enthalten in: ClinicalTrials.gov | 2024

59

Evusheld Japan PMS_Japan Post-Marketing Surveillance (PMS) : General Drug Use-Result Study of Evusheld Intramuscular Injection Set (Treatment and Prevention of Symptomatic Disease Caused by SARS-CoV-2 Infection)

enthalten in: ClinicalTrials.gov | 2024

60

Long COVID-19 Syndrome Lifestyle Intervention Study : Low-Carbohydrate Dietary and Lifestyle Interventions for the Management of Long COVID-19 Syndrome: A Prospective and Interventional Randomized Controlled Pilot Study

enthalten in: ClinicalTrials.gov | 2024